The companies now offer their integrated automated insulin delivery system in Germany, with availability to come in the Netherlands soon. Their updated system combines the company’s Kaleido patch pump with Diabeloop’s DBLG2 algorithm and the Dexcom G7 continuous glucose monitor (CGM).
Running on a user’s smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery every five minutes. This significantly reduces the daily mental burden of diabetes management, the company says. It requires no mandatory meal announcements as well.
Kaleido is a miniature, patch-style insulin pump. ViCentra describes it as the smallest, lightest and most precise insulin patch pump in its class. The pump offers users options in terms of wearability and comes with two durable, rechargeable pumps, eliminating the need to dispose of the pump every three days, while the infusion set lasts for that three-day span. Rather than a traditional syringe pump setup, Kaleido has a micro pumping chamber that uses valves alongside a unique blockage detection system.
G7, Dexcom’s latest-generation all-in-one sensor and transmitter, provides more information in one place with personalized insights, extended-wear design and more compared to previous versions. Its glucose measurements provide data for hybrid closed-loop therapy, all from the smartphone with DBLG2.
This rollout comes on the heels of Diabeloop’s CE mark for the next-generation algorithm paired with G7, announced earlier this year. ViCentra scaled up manufacturing as well to accommodate the expected demand for the offering.
Diabeloop is already processing prescriptions through distributor networks in Germany. For current DBLG1 algorithm users, the transition will occur progressively in the coming months, the company noted.
